Rothschild Investment LLC Macrogenics Inc Transaction History

Rothschild Investment LLC

$1.44 Trillion
Q2 2024

A detailed history of Rothschild Investment LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 20 shares of MGNX stock, worth $66. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$66

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 30, 2024	BUY	$3.31 - $18.51 $66 - $370	20 New	20 $85,000
Q1 2024 Jul 31, 2024	SELL	$9.77 - $21.47 $97 - $214	-10 Reduced 50.0%	10 $147,000

Others Institutions Holding MGNX

# of Institutions

154

Shares Held

60.6M

Call Options Held

218K

Put Options Held

259K

Bellevue Group Ag Kuesnacht, V8

9.94M
Shares

$32.8 Million
0.71% of portfolio
Armistice Capital, LLC New York, NY

6M
Shares

$19.8 Million
0.33% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.14M
Shares

$13.6 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.31M
Shares

$10.9 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $203M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.

Account